Investing
Payment for (Proceeds from) Other Investing Activity
Biogen Payment for (Proceeds from) Other Investing Activity increased by 100.9% to $200K in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $200K to $200K. Over 3 years (FY 2022 to FY 2025), Payment for (Proceeds from) Other Investing Activity shows a downward trend with a 20.4% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
Metric ID:
investing_payments_for_proceeds_from_other_investing_activitiesHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$12.3M | $200K | -$2.2M | $0 | -$22.6M | $700K | $400K | $200K | $10M | $700K | $2.6M | $1.1M | $300K | $200K | $30.4M | -$50.8M | -$22.7M | $200K |
| QoQ Change | — | +101.6% | <-999% | +100.0% | — | +103.1% | -42.9% | -50.0% | >999% | -93.0% | +271.4% | -57.7% | -72.7% | -33.3% | >999% | -267.1% | +55.3% | +100.9% |
| YoY Change | — | — | — | — | -83.7% | +250.0% | +118.2% | — | +144.2% | +0.0% | +550.0% | +450.0% | -97.0% | -71.4% | >999% | <-999% | <-999% | +0.0% |
Range-$50.8M – $30.4M
CAGR-62.1%
Avg YoY Growth-773.5%
Median YoY Growth+0.0%
Current Streak2 quarters growth
Payment for (Proceeds from) Other Investing Activity at Other Companies
Frequently Asked Questions
- What is Biogen's payment for (proceeds from) other investing activity?
- Biogen (BIIB) reported payment for (proceeds from) other investing activity of $200K in Q1 2026.
- How has Biogen's payment for (proceeds from) other investing activity changed year-over-year?
- Biogen's payment for (proceeds from) other investing activity decreased by 0.0% year-over-year, from $200K to $200K.
- What is the long-term trend for Biogen's payment for (proceeds from) other investing activity?
- Over 3 years (2022 to 2025), Biogen's payment for (proceeds from) other investing activity has grown at a 20.4% compound annual growth rate (CAGR), from -$24.6M to -$42.9M.